Clinical and biochemical discriminants between functional hypothalamic amenorrhoea (FHA) and polycystic ovary syndrome (PCOS).

Maria PhylactouSophie A ClarkeBijal PatelCaitlin BaggaleyChanna N Jayasena Thomas W KelseyAlexander N ComninosWaljit Singh Dhillo Ali Abbara

Published in: Clinical endocrinology (2021)

Further data directly comparing the discriminatory potential of these markers to differentiate PCOS and FHA in women with secondary amenorrhoea would be of value in defining an objective probability for PCOS or FHA diagnosis.

Keyphrases

polycystic ovary syndrome
insulin resistance
electronic health record
big data
metabolic syndrome
skeletal muscle
adipose tissue
type diabetes
machine learning
risk assessment